Skip to main content

Table 2 Comparison of the demographic and clinical characteristics between training set and test set

From: N6-Methyladenosine RNA modification in cerebrospinal fluid as a novel potential diagnostic biomarker for progressive multiple sclerosis

 

Training (n = 41)

Test (n = 20)

P

Age (years)

45.0 ± 14.5

44.7 ± 18.2

0.954

Female (%)

26 (63.4%)

11 (55%)

0.528

Diagnosis (%)

 RRMS

21 (51.2%)

11 (55.0%)

0.959

 SPMS

13 (31.7%)

6 (30.0%)

 

 PPMS

7 (17.1%)

3 (15.0%)

Â